Report #2887437

Received Mar 3, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Tinnitus

Symptom narrative

Tinnitus following Shingrix; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tinnitus in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced tinnitus (Verbatim: Tinnitus following Shingrix). The outcome of the tinnitus was not reported. It was unknown if the reporter considered the tinnitus to be related to Shingrix. It was unknown if the company considered the tinnitus to be related to Shingrix. Additional Information: GSK Receipt Date: 24-FEB-2026 This case was reported by a patient via interactive digital media. The batch number was not provided and unable to contact the reporter.